|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Dec 31, 2020
|
FY2019
12 months to Jun 30, 2019
|
FY2018
12 months to Jun 30, 2018
|
|
|---|---|---|---|---|---|
| Revenue, net, including related parties (Note 18) | |||||
| Cost of goods sold | |||||
| Gross (loss) profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Loss in joint venture | |||||
| Changes in fair value of promissory note | |||||
| Other income, net | |||||
| Loss before tax expense | |||||
| Tax expense | |||||
| Net loss | |||||
| Net loss per share - basic and diluted (in usd per share) | |||||
| Weighted average common shares outstanding - basic and diluted (in shares) | |||||
| Net loss per share - basic (in usd per share) | |||||
| Net loss per share - diluted (in usd per share) | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Weighted average common shares outstanding - diluted (in shares) |
Loading...
